Pulmonary Hypertension (PH/PAH)

  2. Home
  3. Education
  4. Top Disease Areas
  5. Pulmonary Hypertension (PH/PAH)
  6. Specialty Area
Page 7 of 9
Results 451 - 525 of 638
9830-icon1
Atopic Dermatitis: Diagnosis and Management in Infants and Children
9830-icon2
Updates in Atopic Dermatitis: Diagnosis and Management in Adults
sma-icon
Are You Ready for Gene Replacement Therapy?
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics?
9916-brown5
The Impact of Anticoagulation Use on IPF Patient Outcomes
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
9840-glassberg2
Evaluation and Diagnosis of IPF
9840-glassberg1
Initial Treatment Decisions of IPF
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
9915-mod2-icon
A History of Hemophilia Treatment: Factor Replacement to Gene Therapy
9915-mod1-icon
Getting to Know Gene Therapy: Terminology and Concepts
9837-coolidge
What if President Calvin Coolidge Was Your Asthma Patient?
9840-0003
Optimizing Management of IPF
New_Concepts_in_the_Pathobiology_of_Asthma_264x150
New Concepts in the Pathobiology of Asthma
9916-king
What are the Most Exciting Things Happening in Pulmonary Disease?
No image set
When Is a Cough Not Just a Cough?
No image set
Diagnosing ILDs Such as IPF and More
No image set
Beyond the Basics: Complex ILD Cases
No image set
PowerPoint Slides: Achieving Better Control of Severe Asthma
9837-roosevelt
How Would You Manage President Theodore Roosevelt’s Asthma Today?
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child
No image set
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult
9916-scholand
New Tools to Improve the Diagnosis of IPF vs Other ILDs
9916-brown
New Research on Therapies for Patients with Pulmonary Fibrosis
9916-richeldi
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
9916-cc-cme
2019 Summer Pulmonary Updates: The Experts Weigh In
No image set
U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine
9833-0001-icon
Urgency for Early Diagnosis and Treatment of SMA
sma-journal-icon_263x0
Gene Therapy for SMA: An Emerging Treatment Option for a Devastating Disease
No image set
Reporting HRCT Findings for ILD from a Multidisciplinary Team
med-doc-aatd
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
med-doc-ph
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
hopa-icon8
Biosimilars: Applying the Science to Hematology/Oncology Practice
9819-ntm case3
Management of Mycobacterium Abscessus Lung Disease
9819-ntm case2
Difficult to Treat Mycobacterium Avium Complex Lung Disease
9819-ntm case1
Management of Mycobacterium Avium Complex Lung Disease
9816-0001
The Latest from a Recent Pulmonary Conference in San Antonio
9816-0010
Updates in Inoperable CTEPH
9816-0009
The Importance of Early Integration of Palliative Care
9816-0006
Management of IPF Patients in 2018
9816-0005
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
9816-00045
Overview of the Latest Clinical Trials in IPF
9816-0003
Evolution of Antifibrotic Therapy in IPF
9816-0002
Take Home Messages from the 2018 CHEST Annual Meeting
9816-0008
What We’re Learning from the IPF-PRO Registry
9816-0007
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
rePlace2
Emerging Treatments for NTM Lung Disease
rePlace2
Nontuberculous Mycobacteria Case 2: Alan
NTM_and_Treatment_Strategies_for_Patients_264x150
NTM and Treatment Strategies for Patients with Cavitary Disease
New_Findings_in_the_Treatment_of_MAC_264x150
New Findings in the Treatment of MAC Lung Disease
Why_You_Should_Pay_Attention_to_NTM_264x150
Why You Should Pay Attention to NTM Treatment Guidelines
Which_of_Your_Patients_Are_at_Risk_for_NTM_264x150
Which of Your Patients Are at Risk for NTM?
Practice_Improvement_through_ILD_Centers_264x150
Practice Improvement through ILD Centers and Community Partnerships
Improving_the_Care_for_IPF_Patients_264x150
Improving the Care for IPF Patients Using a Team-Based Approach
An_Early_Integrated_Palliative_Care_264x150
An Early Integrated Palliative Care Delivery Model for Patients with IPF
rePlace2
Treatment Challenges with MAC Lung Disease
rePlace2
Nontuberculous Mycobacteria: Summary
rePlace2
Treatment Challenges with MABC Lung Disease
rePlace2
Nontuberculous Mycobacteria Case 1: Maria
rePlace2
NTM – To Treat or Not to Treat
rePlace2
Goals of NTM Treatment
rePlace2
Guideline-recommended Treatments for NTM
rePlace2
Diagnosis of NTM
rePlace2
Factors Associated with Respiratory Involvement in NTM
rePlace2
Most Common Species in NTM Lung Disease
rePlace2
Nontuberculous Mycobacteria: Introduction and Epidemiology
9808-0004
What’s New in Spinal Muscular Atrophy? Reporting from Dallas
atopic-derm4
Atopic Dermatitis: Putting it Together (Dermatology)
atopic-derm3
Atopic Dermatitis: Putting it Together (Primary Care)
Page 7 of 9

Search